Market Research Logo

bioMerieux S.A. (BIM) - Financial and Strategic SWOT Analysis Review


Attention: There is an updated edition available for this report.

bioMerieux S.A. (BIM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description – A detailed description of the company’s operations and business divisions.
Corporate strategy – Analyst’s summarization of the company’s business strategy.
SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history – Progression of key events associated with the company.
Major products and services – A list of major products, services and brands of the company.
Key competitors – A list of key competitors to the company.
Key employees – A list of the key executives of the company.
Executive biographies – A brief summary of the executives’ employment history.
Key operational heads – A list of personnel heading key departments/functions.
Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities – A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

bioMerieux S.A. (bioMerieux) designs, develops and manufactures diagnostic systems and reagents for physicians and biologists. The company offers diagnostic solutions such as instruments, reagents and software. bioMerieux products are used diagnosing and managing infectious diseases, cardiovascular diseases and targeted cancers. The company also provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for agri-food, cosmetics and pharmaceutical industries. The company conducts its operations through subsidiaries and a broad network of distributors. bioMerieux is a part of the Institut Merieux group and is headquartered in Marcy l’Etoile, France.

bioMerieux S.A. Key Recent Developments

Jan 21, 2016: bioMerieux – Fourth-Quarter 2015 Business Review
Dec 14, 2015: bioMerieux and Illumina announce the launch of bioMerieux EpiSeq, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections
Nov 04, 2015: bioMerieux Introduces GENE-UP, a New Molecular Diagnostic Solution for Food Pathogen Detection Jointly Developed with BioFire
Oct 22, 2015: bioMerieux – Business review for the nine months ended September 30, 2015
Aug 31, 2015: bioMerieux – First-Half 2015 Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company


Table of Contents
List of Tables
List of Figures
Section 1 - About the Company
bioMerieux S.A. - Key Facts
bioMerieux S.A. - Key Employees
bioMerieux S.A. - Key Employee Biographies
bioMerieux S.A. - Major Products and Services
bioMerieux S.A. - Medical Equipment Pipeline Products Data
bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A. - History
bioMerieux S.A. - Company Statement
bioMerieux S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
bioMerieux S.A. - Key Manufacturing Facilities
Section 2 – Company Analysis
bioMerieux S.A. - Business Description
Business Description - Clinical Applications
Clinical Applications - Overview
Clinical Applications - Financials
Clinical Applications - Market View
Clinical Applications - Technology
Business Description - Industrial Applications
Industrial Applications - Overview
Industrial Applications - Financials
Industrial Applications - Technology
bioMerieux S.A. - Corporate Strategy
bioMerieux S.A. - SWOT Analysis
SWOT Analysis - Overview
bioMerieux S.A. - Strengths
Strength - Strategic Acquisitions
Strength - Clinical Applications Franchise
Strength - Proprietary Technologies
Strength - Strong Research and Development Activities
bioMerieux S.A. - Weaknesses
Weakness - Product Safety Concerns
Weakness - Declining Cash Reserves
bioMerieux S.A. - Opportunities
Opportunity - Growing In Vitro Diagnostics Market
Opportunity - Regulatory Approvals and New Product Launches
Opportunity - Market Opportunity - Infectious Disease
Opportunity - Strategic Initiatives
bioMerieux S.A. - Threats
Threat - Competitive Environment
Threat - Stringent Governmental Regulations
Threat - Introduction of Innovative Technologies
bioMerieux S.A. - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
bioMerieux S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
bioMerieux S.A., Medical Equipment, Deals By Type, 2010 to YTD 2016
bioMerieux S.A., Recent Deals Summary
Section 5 – Company’s Recent Developments
Jan 26, 2016: BioFire’s FilmArray Meningitis/Encephalitis Panel Gets CE Marked
Jan 21, 2016: bioMerieux – Fourth-Quarter 2015 Business Review
Dec 14, 2015: bioMerieux and Illumina announce the launch of bioMerieux EpiSeq, a revolutionary Next-Generation Sequencing service for epidemiological monitoring of bacterial infections
Dec 07, 2015: Yale Study Shows bioTheranostics’ Breast Cancer Index Molecular Test Impacts Extended Endocrine Therapy Decisions in Clinical Practice
Nov 04, 2015: bioMerieux Introduces GENE-UP, a New Molecular Diagnostic Solution for Food Pathogen Detection Jointly Developed with BioFire
Oct 22, 2015: bioMerieux – Business review for the nine months ended September 30, 2015
Oct 09, 2015: BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray Meningitis/Encephalitis panel continuing its extremely favorable business momentum
Oct 06, 2015: bioTheranostics Announces Collaboration with DeNovo Sciences to Evaluate Its Proprietary Cancer
Aug 31, 2015: bioMerieux – First-Half 2015 Results
Jul 17, 2015: bioMerieux - First-Half 2015 Business Review
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
bioMerieux S.A., Key Facts
bioMerieux S.A., Key Employees
bioMerieux S.A., Key Employee Biographies
bioMerieux S.A., Major Products and Services
bioMerieux S.A. Number of Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Number of Pipeline Products by Development Stage
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A., History
bioMerieux S.A., Subsidiaries
bioMerieux S.A., Key Manufacturing Facilities
bioMerieux S.A., Key Competitors
bioMerieux S.A., Annual Ratios
bioMerieux S.A., Interim Ratios
bioMerieux S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
bioMerieux S.A., Medical Equipment, Deals By Type, 2010 to YTD 2016
bioMerieux S.A., Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
bioMerieux S.A. Pipeline Products by Equipment Type
bioMerieux S.A. Pipeline Products by Development Stage
bioMerieux S.A., Performance Chart (2011 - 2015)
bioMerieux S.A., Ratio Charts
bioMerieux S.A., Medical Equipment, Deals By Year, 2010 to YTD 2016
bioMerieux S.A., Medical Equipment, Deals by Type, 2010 to YTD 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report